Thomas W Wilson Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

6/2002

The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas W Wilson Research Topics

Disease

11	Hypertension (High Blood Pressure) 01/2017 - 06/2002
2	Hyperaldosteronism (Conn Syndrome) 01/2016 - 01/2007
2	Coronary Artery Disease (Coronary Atherosclerosis) 05/2014 - 02/2012
2	Myocardial Infarction 07/2007 - 08/2005
2	Unstable Angina 07/2007 - 08/2005
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2018
1	Isolated Systolic Hypertension 01/2017
1	Frailty 01/2017
1	Ovarian Neoplasms (Ovarian Cancer) 01/2017
1	Acute Coronary Syndrome 01/2017
1	Coronary Disease (Coronary Heart Disease) 02/2016
1	Hyperkalemia 01/2016
1	Stable Angina 01/2016
1	Myocardial Ischemia (Ischemic Heart Diseases) 05/2014
1	Atrial Fibrillation 02/2010
1	Stroke (Strokes) 07/2007
1	Heart Diseases (Heart Disease) 01/2007
1	Ischemic Stroke 08/2005
1	Chronic Disease (Chronic Diseases) 05/2005
1	Insulin Resistance 09/2004
1	Obesity 09/2004
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 09/2004
1	Body Weight (Weight, Body) 09/2004
1	Hypotension (Low Blood Pressure) 02/2003
1	Glaucoma 02/2003
1	Bradycardia 02/2003
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2002

Drug/Important Bio-Agent (IBA)

4	Antihypertensive Agents (Antihypertensives)IBA 01/2017 - 06/2002
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 05/2005
3	SaltsIBA 05/2014 - 11/2006
2	SodiumIBA 05/2014 - 11/2006
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2007 - 05/2005
1	130-nm albumin-bound paclitaxelIBA 09/2018
1	folfirinoxIBA 09/2018
1	Gemcitabine FDA Link 09/2018
1	PlatinumIBA 01/2017
1	LipidsIBA 01/2016
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2016
1	Dietary PotassiumIBA 01/2016
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2014
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2014
1	HDL CholesterolIBA 02/2012
1	Blood Glucose (Blood Sugar)IBA 02/2012
1	Vitamin D FDA LinkGeneric 06/2011
1	MercuryIBA 02/2010
1	Clofibrate FDA Link 01/2008
1	Atenolol (Tenormin)FDA LinkGeneric 07/2007
1	CalciumIBA 07/2007
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 07/2007
1	Mineralocorticoid Receptor AntagonistsIBA 01/2007
1	Angiotensin Receptor AntagonistsIBA 01/2007
1	20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA 11/2006
1	PPAR alphaIBA 09/2004
1	PPAR-gamma AgonistsIBA 09/2004
1	Rosiglitazone (Avandia)FDA Link 09/2004
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2004
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 02/2003
1	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 02/2003

Therapy/Procedure

5	Therapeutics 01/2017 - 01/2007
2	Drug Therapy (Chemotherapy) 09/2018 - 05/2014
1	Combination Drug Therapy (Combination Chemotherapy) 09/2018
1	Time-to-Treatment 09/2018
1	Adrenalectomy 01/2016
1	Blood Pressure Monitors 02/2010
1	Sphygmomanometers 02/2010
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 08/2005